Concepedia

Ives Ntambwe

IN

Statistics

Publications

3

Citations

74

H-Index

3

Active since

2023

Affiliations

Bristol-Myers Squibb (United States)(Current)

Ives Ntambwe is an author at Bristol-Myers Squibb (United States) specializing in lung cancer, medicine, and oncology.

Top concepts

Publications per year

2023–2023

3

Publications

3

Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trial

Hossein Borghaei, Kenneth J. O’Byrne, Luis Paz‐Ares et al. · ESMO Open · 2023 · 41 citations · Full text

Neoadjuvant nivolumab plus chemotherapy in resectable non‐small‐cell lung cancer in Japanese patients from <scp>CheckMate</scp> 816

Tetsuya Mitsudomi, Hiroyuki Ito, Morihito Okada et al. · Cancer Science · 2023 · 18 citations · Full text

Emulating Randomized Controlled Trials with Hybrid Control Arms in Oncology: A Case Study

Sanhita Sengupta, Ives Ntambwe, Katherine Tan et al. · Clinical Pharmacology & Therapeutics · 2023 · 15 citations · Full text

, , +18

1–3 of 3